• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

从植物香椿中鉴定新型天然产物 SHP2 抑制剂:体外和计算研究。

Identification of the novel natural product inhibitors of SHP2 from the plant Toona sinensis: In vitro and in silico study.

机构信息

Shandong Key Laboratory of Clinical Applied Pharmacology, Department of Pharmacy, Affiliated Hospital of Weifang Medical University, Weifang 261041, Shandong Province, China; Clinical Research Center, Affiliated Hospital of Weifang Medical University, Weifang 261041, Shandong Province, China.

School of Pharmacy, Weifang Medical University, Weifang 261053, Shandong Province, China.

出版信息

Int J Biol Macromol. 2022 Nov 30;221:679-690. doi: 10.1016/j.ijbiomac.2022.09.042. Epub 2022 Sep 9.

DOI:10.1016/j.ijbiomac.2022.09.042
PMID:36096249
Abstract

In this study, we tested the inhibitory activity of 45 natural products extracted from the plant Toona sinensis on SHP2 protein, and identified four natural product inhibitors. The natural product 1,2,3,6-Tetragalloylglucose (A-1) was first reported as a competitive inhibitor of SHP2, with an IC value of 0.20 ± 0.029 μM and the selectivity of 1.8-fold and 4.35-fold to high homologous proteins SHP1 and PTP1B, respectively. Compound A-1 also showed high inhibitory activity on SHP2-E76K and SHP2-E76A mutants, with IC values of 0.95 ± 0.21 μM and 0.29 ± 0.045 μM, respectively. Cell viability assay showed that compound A-1 could inhibit the proliferation of a variety of cancer cells. Apoptosis assay showed that compound A-1 could effectively induce apoptosis of KRAS-mut NCI-H23 and KRAS-mut A549 cells. Western blot assay showed that compound A-1 could down regulate the phosphorylation levels of Erk1/2 and Akt in NCI-H23 and A549 cells. Molecular docking showed that compound A-1 could effectively dock to the catalytic active region of SHP2. Molecular dynamics simulation explored the effect of compound A-1 on SHP2, revealing the deep-seated binding mechanism. This study would provide valuable clues for the development of SHP2 and its mutant inhibitors.

摘要

在这项研究中,我们测试了 45 种从香椿植物中提取的天然产物对 SHP2 蛋白的抑制活性,并鉴定出了四种天然产物抑制剂。天然产物 1,2,3,6-四没食子酰葡萄糖(A-1)首次被报道为 SHP2 的竞争性抑制剂,其 IC 值为 0.20±0.029μM,对高同源蛋白 SHP1 和 PTP1B 的选择性分别为 1.8 倍和 4.35 倍。化合物 A-1 对 SHP2-E76K 和 SHP2-E76A 突变体也表现出高抑制活性,IC 值分别为 0.95±0.21μM 和 0.29±0.045μM。细胞活力测定表明,化合物 A-1 能够抑制多种癌细胞的增殖。凋亡测定表明,化合物 A-1 能够有效诱导 KRAS-mut NCI-H23 和 KRAS-mut A549 细胞凋亡。Western blot 测定表明,化合物 A-1 能够下调 NCI-H23 和 A549 细胞中 Erk1/2 和 Akt 的磷酸化水平。分子对接表明,化合物 A-1 能够有效地对接 SHP2 的催化活性区域。分子动力学模拟探索了化合物 A-1 对 SHP2 的影响,揭示了其深层次的结合机制。这项研究为 SHP2 及其突变体抑制剂的开发提供了有价值的线索。

相似文献

1
Identification of the novel natural product inhibitors of SHP2 from the plant Toona sinensis: In vitro and in silico study.从植物香椿中鉴定新型天然产物 SHP2 抑制剂:体外和计算研究。
Int J Biol Macromol. 2022 Nov 30;221:679-690. doi: 10.1016/j.ijbiomac.2022.09.042. Epub 2022 Sep 9.
2
Design, synthesis, activity and molecular dynamics studies of 1,3,4-thiadiazole derivatives as selective allosteric inhibitors of SHP2 for the treatment of cancer.设计、合成、活性及 1,3,4-噻二唑衍生物作为 SHP2 别构抑制剂用于癌症治疗的分子动力学研究。
Eur J Med Chem. 2023 Oct 5;258:115585. doi: 10.1016/j.ejmech.2023.115585. Epub 2023 Jun 24.
3
Discovery of ellagic acid as a competitive inhibitor of Src homology phosphotyrosyl phosphatase 2 (SHP2) for cancer treatment: In vitro and in silico study.发现鞣花酸是一种Src 同源性磷酸酪氨酸磷酸酶 2(SHP2)的竞争性抑制剂,可用于癌症治疗:体外和计算研究。
Int J Biol Macromol. 2024 Jan;254(Pt 2):127845. doi: 10.1016/j.ijbiomac.2023.127845. Epub 2023 Nov 5.
4
Hexachlorophene, a selective SHP2 inhibitor, suppresses proliferation and metastasis of KRAS-mutant NSCLC cells by inhibiting RAS/MEK/ERK and PI3K/AKT signaling pathways.六氯酚是一种选择性SHP2抑制剂,通过抑制RAS/MEK/ERK和PI3K/AKT信号通路来抑制KRAS突变型非小细胞肺癌细胞的增殖和转移。
Toxicol Appl Pharmacol. 2022 Apr 15;441:115988. doi: 10.1016/j.taap.2022.115988. Epub 2022 Mar 18.
5
Design, synthesis and biological evaluation of pyridine derivatives as selective SHP2 inhibitors.设计、合成并评价吡啶衍生物作为选择性 SHP2 抑制剂。
Bioorg Chem. 2020 Jul;100:103875. doi: 10.1016/j.bioorg.2020.103875. Epub 2020 Apr 25.
6
Benzo[c][1,2,5]thiadiazole derivatives: A new class of potent Src homology-2 domain containing protein tyrosine phosphatase-2 (SHP2) inhibitors.苯并[c][1,2,5]噻二唑衍生物:一类新型强效含Src同源2结构域蛋白酪氨酸磷酸酶2(SHP2)抑制剂。
Bioorg Med Chem Lett. 2017 Dec 1;27(23):5154-5157. doi: 10.1016/j.bmcl.2017.10.059. Epub 2017 Oct 26.
7
Discovery of 1H-pyrazolo[3,4-]pyrazine derivatives as selective allosteric inhibitor of protein tyrosine phosphatase SHP2 for the treatment of KRAS-mutant non-small cell lung cancer.发现1H-吡唑并[3,4-]吡嗪衍生物作为蛋白酪氨酸磷酸酶SHP2的选择性变构抑制剂用于治疗KRAS突变型非小细胞肺癌。
J Biomol Struct Dyn. 2024 Jan 23:1-9. doi: 10.1080/07391102.2024.2308771.
8
Identification of demethylincisterol A as a selective inhibitor of protein tyrosine phosphatase Shp2.鉴定去甲基肉豆蔻甾醇A为蛋白酪氨酸磷酸酶Shp2的选择性抑制剂。
Eur J Pharmacol. 2017 Jan 15;795:124-133. doi: 10.1016/j.ejphar.2016.12.012. Epub 2016 Dec 8.
9
An efficient method based on an inhibitor-enzyme complex to screen an active compound against lipase from .一种基于抑制剂 - 酶复合物的高效方法,用于筛选针对来自……的脂肪酶的活性化合物。 (原文此处“from”后缺少具体内容)
Food Funct. 2021 Nov 1;12(21):10806-10812. doi: 10.1039/d1fo01542g.
10
Synthesis of small peptide compounds, molecular docking, and inhibitory activity evaluation against phosphatases PTP1B and SHP2.小肽化合物的合成、分子对接以及对蛋白酪氨酸磷酸酶1B(PTP1B)和含Src同源2结构域蛋白酪氨酸磷酸酶2(SHP2)的抑制活性评估。
Drug Des Devel Ther. 2018 Dec 5;12:4139-4147. doi: 10.2147/DDDT.S186614. eCollection 2018.